The goal of the Women’s Oncology Program (WON) is:
- To accelerate the pace and expand the range of fundamental discovery research about women’s cancers
- To facilitate the translation of new scientific findings into the clinic.
WON Members study novel pathways by which hormones and growth factors regulate growth and metastasis of women’s cancers; identify potential new therapeutic targets or prognostic indicators for response or resistance to therapy; and perform clinical trials to test efficacy of therapeutic agents in treating these cancers. Program leadership has organized WON around three research themes:
- Steroid hormone action and steroid-dependent cancers
- Growth factor and cytokine promotion of tumor development and metastasis
- Investigator-initiated clinical research and development of novel clinical research tools
Professor of Medicine and Physiology Margaret A. Shupnik, PhD and Susan C. Modesitt, MD lead the Program. The Program represents a wide variety of expertise. The following areas of support have enabled the success of WON research initiatives, which have become increasingly cancer focused and interactive: funding for faculty recruitment and retention; funding for information exchange forums, such as the CC Seminar Series, WON research meetings, and the Program Retreat; Cancer Center Pilot Project Funds; and support from the UVA Cancer Center Shared Resources.